Log in to save to my catalogue

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approv...

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a9ae2928bdb416d9daca065b1f5b9b1

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment

About this item

Full title

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2024-04, Vol.29 (9), p.1909

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The burden of human schistosomiasis, a known but neglected tropical disease in Sub-Saharan Africa, has been worrisome in recent years. It is becoming increasingly difficult to tackle schistosomiasis with praziquantel, a drug known to be effective against all
, due to reports of reduced efficacy and resistance. Therefore, this study seeks to inve...

Alternative Titles

Full title

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5a9ae2928bdb416d9daca065b1f5b9b1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5a9ae2928bdb416d9daca065b1f5b9b1

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules29091909

How to access this item